Aristeia Capital’s Vicarious Surgical Inc Warrants RBOT.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-522,521
Closed -$11.5K 683
2025
Q3
$11.5K Hold
522,521
﹤0.01% 512
2025
Q2
$15.2K Hold
522,521
﹤0.01% 455
2025
Q1
$20.9K Sell
522,521
-9,725
-2% -$291 ﹤0.01% 382
2024
Q4
$11.3K Hold
532,246
﹤0.01% 356
2024
Q3
$25K Hold
532,246
﹤0.01% 296
2024
Q2
$16K Hold
532,246
﹤0.01% 289
2024
Q1
$41.5K Sell
532,246
-13,491
-2% -$1.23K ﹤0.01% 208
2023
Q4
$13.6K Hold
545,737
﹤0.01% 159
2023
Q3
$41.4K Sell
545,737
-81,751
-13% -$13.3K ﹤0.01% 140
2023
Q2
$138K Sell
627,488
-135,463
-18% -$32.5K ﹤0.01% 134
2023
Q1
$281K Sell
762,951
-120,073
-14% -$35.2K 0.01% 220
2022
Q4
$150K Hold
883,024
﹤0.01% 335
2022
Q3
$400K Sell
883,024
-24,522
-3% -$12.4K 0.01% 421
2022
Q2
$295K Sell
907,546
-228,472
-20% -$128K 0.01% 400
2022
Q1
$920K Sell
1,136,018
-3,099
-0.3% -$3.11K 0.02% 383
2021
Q4
$2.41M Buy
1,139,117
+96,329
+9% +$196K 0.04% 372
2021
Q3
$2.31M Buy
+1,042,788
New +$2.11M 0.04% 317

Aristeia Capital's RBOT.WS Position: Q4 2025 in Review

Aristeia Capital sold out of Vicarious Surgical Inc Warrants (RBOT.WS) in Q4 2025, closing a stake of 522,521 shares — an estimated $11.5K sold.

Aristeia Capital first reported a position in RBOT.WS in Q3 2021 and held it in 17 quarters. The position peaked at $2.41M in Q4 2021. 0 funds tracked by Wall St. Rank hold RBOT.WS as of Q4 2025.

  • Aristeia Capital reported no remaining Vicarious Surgical Inc Warrants position as of Q4 2025 after selling out during the quarter.
  • Aristeia Capital sold 522,521 Vicarious Surgical Inc Warrants shares in Q4 2025, an estimated $11.5K.
  • Aristeia Capital first reported a position in Vicarious Surgical Inc Warrants in Q3 2021 and held it in 17 quarters.
  • Aristeia Capital's Vicarious Surgical Inc Warrants position peaked at $2.41M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Vicarious Surgical Inc Warrants as of Q4 2025.

Based on Aristeia Capital's 13F filing for Q4 2025, filed 17 Feb 2026.